Long‐term safety and efficacy of lacosamide and controlled‐release carbamazepine monotherapy in patients with newly diagnosed epilepsy

OBJECTIVE: A large‐scale, double‐blind trial (SP0993; NCT01243177) demonstrated that lacosamide was noninferior to controlled‐release carbamazepine (carbamazepine‐CR) in terms of efficacy, and well tolerated as first‐line monotherapy in patients (≥16 years of age) with newly diagnosed epilepsy. We r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Epilepsia
Glavni autori: Ben‐Menachem, Elinor, Grebe, Hans Peter, Terada, Kiyohito, Jensen, Lori, Li, Ting, De Backer, Marc, Steiniger‐Brach, Björn, Gasalla, Teresa, Brock, Melissa, Biton, Victor
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Full‐length Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6988520/
https://ncbi.nlm.nih.gov/pubmed/31755090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.16381
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items